Download
https://medicaldialogues.in/medicine/news/sglt2-inhibitors-tied-to-lower-risk-of-incident-gout-vis-a-vis-sulfonylureasin-diabetes-patients-jama-127433
Among diabetes patients, SGLT2 inhibitors less likely to cause gout compared to sulfonylureas: JAMA
Share